DOI: Published online: May 1, 2025 1 Department of Medicine, Seoul National University College of Medicine, Seoul, Korea 2 Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea 3 Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul, Korea 4 Neuroscience Research Institute, Seoul National University College of Medicine, Seoul, Korea 5 Wide River Institute of Immunology, Seoul National University, Hongcheon, Korea 6 Department of Brain and Cognitive Sciences, Seoul National University, Seoul, Korea Corresponding author: Hyung Jin Choi Department of Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: [email protected] Copyright 2025 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
Where Things Stand Right Now Lilly has submitted orforglipron for regulatory review in over 40 countries
Asking do GLP-1 patches work for weight loss is important, because misinformation can lead people to spend months relying on an unproven patch while delaying effective treatment
Neurodegenerative diseases T2D is a risk factor for cognitive dysfunction and for developing Alzheimers disease (62)
